Liquidia (LQDA) Other Non-Current Assets (2019 - 2026)
Liquidia (LQDA) recorded quarterly Other Non-Current Assets of $3.5 million in Q1 2026, little changed quarter-over-quarter from $3.5 million in Q4 2025, and down 77.45% on a YoY basis from $15.5 million in Q1 2025.
Liquidia (LQDA) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Liquidia's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 77.45% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 77.45% YoY), while the FY2025 annual figure was $3.5 million, down 67.91% from the prior year.
- Other Non-Current Assets was $3.5 million for Q1 2026 at Liquidia, roughly flat from $3.5 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $15.5 million in Q1 2025 to a low of $224000.0 in Q1 2024.
- Historically, Other Non-Current Assets has averaged $3.3 million across 5 years, with a median of $307000.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets surged 6838.39% in 2025, then sank 77.45% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $307000.0 in 2022, then declined by 6.51% to $287000.0 in 2023, then surged by 3704.18% to $10.9 million in 2024, then slumped by 67.91% to $3.5 million in 2025, then changed by 0.0% to $3.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $3.5 million (Q1 2026), $3.5 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 3.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 8.95 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 15.54 Mn |
| Dec 31, 2024 | 10.92 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 224,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 30, 2023 | 287,000.00 |
| Jun 30, 2023 | 260,000.00 |
| Mar 31, 2023 | 307,000.00 |
| Dec 31, 2022 | 307,000.00 |
| Sep 30, 2022 | 307,000.00 |
| Jun 30, 2022 | 307,000.00 |
| Mar 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | 312,925.00 |
| Jun 30, 2021 | 318,331.00 |